Evaxion Biotech A/S logo

EVAXEvaxion Biotech A/S

EVAX Stock Price, Valuation & Chart | Evaxion Biotech A/S

Compare

EVAX Historical price chart

EVAX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization19.39M
PE Ratio-2.09
EPS-1.47
Trading Volume59.49K
Today's High/Low3.19/2.99
Dividend Yield0.00
52 Week High/Low12.15/2.52
Shares Outstanding6.32M
EVAX Financial Statement
EVAX Analyst ratings
EVAX Analysis & performance metrics

EVAX Company profile

Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral…

EVAX Management team

Management
Christian Kanstrup M.Sc.CEO
Chief Executive Officer
Birgitte Rono Ph.D.
Chief Scientific Officer
Andreas Holm Mattsson
Founder & Chief AI Officer
Thomas Frederik Schmidt M.Sc.CFO
Interim Chief Financial Officer
Total 4 executives

EVAX Frequently asked questions

What is Evaxion Biotech A/S (EVAX) Stock Price?

Current stock price of Evaxion Biotech A/S (EVAX) stock is $3.070. The stock price is +3.02% higher in the session. The intraday range can be seen from this page. Volume of Evaxion Biotech A/S (EVAX) stock is 59.49K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Evaxion Biotech A/S (EVAX) stock price going up or down today?

The stock price of Evaxion Biotech A/S (EVAX) can change with earnings, company news, and overall market sentiment. Evaxion Biotech A/S operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Evaxion Biotech A/S stock expensive at its current price?

Whether Evaxion Biotech A/S looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for EVAX on this page is -2.09. EPS on this page is -1.47. Compare those figures with peers and growth expectations before deciding if the current Evaxion Biotech A/S price is justified.

How has the stock price of Evaxion Biotech A/S (EVAX) performed historically?

Historical performance for Evaxion Biotech A/S (EVAX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how EVAX reacted to past earnings and market events.

Should I buy Evaxion Biotech A/S (EVAX) stock, at this price?

Buying Evaxion Biotech A/S (EVAX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.